Upon treatment with JQ1, a bromodomain and extraterminal domain (BET) inhibitor, MYCN, MYCNOT, and mrtl nearly vanish, coinciding with a notable increase in apoptosis levels in pediatric embryonal tumor cell lines that rely on MYC to maintain an undifferentiated phenotype. Here, MYCN is linked to neoplasm.